Pages that link to "Q35839114"
Jump to navigation
Jump to search
The following pages link to Macaques immunized with HLA-DR are protected from challenge with simian immunodeficiency virus. (Q35839114):
Displaying 50 items.
- XMRV: A New Virus in Prostate Cancer? (Q24626672) (← links)
- HIV-1 prophylactic vaccines: state of the art (Q26740042) (← links)
- Current Advances in Virus-Like Particles as a Vaccination Approach against HIV Infection (Q26775082) (← links)
- A brief history of the global effort to develop a preventive HIV vaccine (Q26851165) (← links)
- The role of innate APOBEC3G and adaptive AID immune responses in HLA-HIV/SIV immunized SHIV infected macaques (Q27305204) (← links)
- Vaccine development against HIV-1: current perspectives and future directions. (Q30329791) (← links)
- Progress in HIV vaccine research. (Q30331429) (← links)
- Alloimmunization for immune-based therapy and vaccine design against HIV/AIDS. (Q33546852) (← links)
- Incorporation of HLA-DR into the envelope of human immunodeficiency virus type 1 in vivo: correlation with stage of disease and presence of opportunistic infection (Q33603923) (← links)
- Limited breadth of the protective immunity elicited by simian immunodeficiency virus SIVmne gp160 vaccines in a combination immunization regimen (Q33639684) (← links)
- Protection of macaques against intrarectal infection by a combination immunization regimen with recombinant simian immunodeficiency virus SIVmne gp160 vaccines (Q33644522) (← links)
- Infectious cellular load in human immunodeficiency virus type 1 (HIV-1)-infected individuals and susceptibility of peripheral blood mononuclear cells from their exposed partners to non-syncytium-inducing HIV-1 as major determinants for HIV-1 transmi (Q33781934) (← links)
- Inactivation of human immunodeficiency virus type 1 infectivity with preservation of conformational and functional integrity of virion surface proteins. (Q33784777) (← links)
- Protection of Macaca nemestrina from disease following pathogenic simian immunodeficiency virus (SIV) challenge: utilization of SIV nucleocapsid mutant DNA vaccines with and without an SIV protein boost (Q33813173) (← links)
- Alteration of zinc-binding residues of simian immunodeficiency virus p8(NC) results in subtle differences in gag processing and virion maturation associated with degradative loss of mutant NC. (Q33834585) (← links)
- Prior mucosal exposure to heterologous cells alters the pathogenesis of cell-associated mucosal feline immunodeficiency virus challenge. (Q33968779) (← links)
- Assessment of HIV vaccine development: past, present, and future (Q34050712) (← links)
- Virus maturation by budding (Q34068037) (← links)
- Down-regulation of CD81 in human cells producing HCV-E1/E2 retroVLPs (Q34175410) (← links)
- The antiviral activity of antibodies in vitro and in vivo. (Q34212487) (← links)
- Chronic immune activation and inflammation in the pathogenesis of AIDS and cancer (Q34554736) (← links)
- Immunization with recombinant HLA classes I and II, HIV-1 gp140, and SIV p27 elicits protection against heterologous SHIV infection in rhesus macaques. (Q35077438) (← links)
- Complement-mediated virus infectivity neutralisation by HLA antibodies is associated with sterilising immunity to SIV challenge in the macaque model for HIV/AIDS (Q35097510) (← links)
- Alloantigen-based AIDS vaccine: revisiting a "rightfully" discarded promising strategy (Q35161553) (← links)
- HIV-1 Gag p17 presented as virus-like particles on the E2 scaffold from Geobacillus stearothermophilus induces sustained humoral and cellular immune responses in the absence of IFNγ production by CD4+ T cells. (Q35745815) (← links)
- Feline immunodeficiency virus vaccination: characterization of the immune correlates of protection (Q35871792) (← links)
- Contribution of virion ICAM-1 to human immunodeficiency virus infectivity and sensitivity to neutralization (Q35887432) (← links)
- Host factors influencing susceptibility to HIV infection and AIDS progression (Q35995936) (← links)
- Lessons in nonhuman primate models for AIDS vaccine research: from minefields to milestones (Q36009232) (← links)
- Quantitation of HLA proteins incorporated by human immunodeficiency virus type 1 and assessment of neutralizing activity of anti-HLA antibodies (Q36424011) (← links)
- Inhibition of HIV-1 entry by antibodies: potential viral and cellular targets (Q36631937) (← links)
- Comparative characterization of transfection- and infection-derived simian immunodeficiency virus challenge stocks for in vivo nonhuman primate studies (Q36760147) (← links)
- Quantitation of HLA Class II Protein Incorporated into Human Immunodeficiency Type 1 Virions Purified by Anti-CD45 Immunoaffinity Depletion of Microvesicles (Q37059703) (← links)
- CD44 microbeads accelerate HIV-1 infection in T cells (Q37236404) (← links)
- Two-dimensional gel-based approaches for the assessment of N-Linked and O-GlcNAc glycosylation in human and simian immunodeficiency viruses (Q37447351) (← links)
- Vaccine protection by a triple deletion mutant of simian immunodeficiency virus. (Q39874667) (← links)
- Identification of host proteins associated with retroviral vector particles by proteomic analysis of highly purified vector preparations. (Q40046367) (← links)
- Neutralizing antibodies decrease the envelope fluidity of HIV-1. (Q40075228) (← links)
- Interaction between the cytoplasmic domain of ICAM-1 and Pr55Gag leads to acquisition of host ICAM-1 by human immunodeficiency virus type 1. (Q40214088) (← links)
- Envelope glycoproteins are not required for insertion of host ICAM-1 into human immunodeficiency virus type 1 and ICAM-1-bearing viruses are still infectious despite a suboptimal level of trimeric envelope proteins (Q40548352) (← links)
- Neutralization of HIV-1 by antibody (Q41103020) (← links)
- Macaque models for AIDS vaccine development (Q41103089) (← links)
- FIV infection of the domestic cat: an animal model for AIDS. (Q41459259) (← links)
- HIV-specific cytolytic CD4 T cell responses during acute HIV infection predict disease outcome (Q41937295) (← links)
- Rational design of HIV vaccines and microbicides: report of the EUROPRISE network annual conference 2010. (Q42726161) (← links)
- Working group consultation: alloimmunity as a vaccine approach against HIV/AIDS: National Institutes of Health Meeting Report, May 24, 2012. (Q43163879) (← links)
- Cytoskeletal proteins bound to heat-shock protein 70 may elicit resistance to simian immunodeficiency virus infection of CD4(+) T cells (Q43225467) (← links)
- Xenogeneic and allogeneic anti-MHC immune responses induced by plasmid DNA immunization (Q43866952) (← links)
- Long-term protection of chimpanzees against high-dose HIV-1 challenge induced by immunization (Q44592013) (← links)
- Mucosal challenge with cell-associated or cell-free feline immunodeficiency virus induces rapid and distinctly different patterns of phenotypic change in the mucosal and systemic immune systems (Q44870958) (← links)